인쇄하기
취소

Ilyang’s Supect covered by health insurance

Published: 2012-06-27 06:58:00
Updated: 2012-06-27 06:58:00
A novel leukemia drug Supect, which was developed by Ilyang Pharm, can be covered by the national health insurance.

The National Health Insurance Corporation decided to get Supect (rodotinib) 800 mg at 64,000 won per pill, the company said on Monday.

The daily treatments cost for Supect is lower than that for Tasigna (92,200 won per pill) and Glivec (68,376 won one year after patent expir...

Fees

- Email service daily and homepage access.
  1. $300 per month.
  2. 5 Email holders per each company.
  3. Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.